NYSE:ZVO Zovio (ZVO) Stock Price, News & Analysis → Tiny Biotech Stock Wins $75 Billion Patent (From Behind the Markets) (Ad) Free ZVO Stock Alerts Add Compare Share Share Today's Range N/A50-Day Range$0.00▼$0.0952-Week Range N/AVolumeN/AAverage Volume2.07 million shsMarket Capitalization$3.18 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsSocial MediaStock AnalysisChartCompetitorsSocial Media Get Zovio alerts: Email Address Ad Behind the MarketsTiny Biotech Stock Wins $75 Billion PatentA little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.Find out more here >>> About Zovio Stock (NYSE:ZVO)Zovio, Inc. operates as an education technology services company that partners with higher education institutions and employers to deliver solutions and learning experiences. It provides student recruitment and enrollment systems, retention strategies, educational tools, and curriculums. The company was founded by Wayne Clugston and Andrew S. Clark in May 1999 and is headquartered in Chandler, AZ.Read More Ad AltimetrySecret Bull Market Starts in This Unusual Sector"We're only at the very beginning of a new wave that could deliver 500%-plus gains in the years to come." In fact, 50 small companies related to this sector have already soared 100% or more in a recent 90-day stretch. Click for my No. 1 investment, all free of charge, click here. ZVO Stock News HeadlinesApril 12, 2024 | americanbankingnews.comStockNews.com Begins Coverage on Zovio (NYSE:ZVO)November 11, 2023 | morningstar.comEdvantage Group Holdings Ltd 00382April 19, 2024 | Behind the Markets (Ad)Tiny Biotech Stock Wins $75 Billion PatentA little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.October 10, 2023 | fool.comBeachbody (NYSE: BODY)October 4, 2023 | fool.comCluey (ASX: CLU)May 28, 2023 | fool.comF45 Training (NYSE: FXLV)See More Headlines Receive ZVO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Zovio and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeNYSE SectorEducational Services Industry Colleges, Universities, and Professional Schools Sub-IndustryN/A Current SymbolNYSE:ZVO CUSIPN/A CIKN/A WebN/A Phone(858) 668-2586FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$230.00 million Price / Sales0.00 Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares34,221,000Free FloatN/AMarket Cap$3.18 million OptionableNot Optionable Beta1.36 Beginner's Guide to Pot Stock InvestingClick the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise. Get This Free Report Key ExecutivesRandy J. HendricksChief Executive Officer & DirectorKevin S. RoyalChief Financial Officer & Executive Vice PresidentVickie L. SchrayChief External Affairs Officer & Executive VPJohn W. SemelChief Strategy Officer & Executive Vice PresidentMatthew D. MitchellSecretary, Senior Vice President & General CounselKey CompetitorsMeten EdtechX Education GroupNASDAQ:METXWView All Competitors ZVO Stock Analysis - Frequently Asked Questions What other stocks do shareholders of Zovio own? Based on aggregate information from My MarketBeat watchlists, some companies that other Zovio investors own include Advanced Micro Devices (AMD), Telefonaktiebolaget LM Ericsson (publ) (ERIC), Pfizer (PFE), Zynga (ZNGA), CymaBay Therapeutics (CBAY), Remark (MARK), Himax Technologies (HIMX), Moderna (MRNA), Bank of America (BAC). How do I buy shares of Zovio? Shares of ZVO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NYSE:ZVO) was last updated on 4/19/2024 by MarketBeat.com Staff From Our PartnersThe “Perfect Storm” for GoldGold Safe ExchangeTiny Biotech Stock Wins $75 Billion PatentBehind the MarketsBiden’s $374B Giveaway Into This SectorDTIHe Is Giving Away BitcoinCrypto Swap ProfitsSHOCKING Crypto Leak…Crypto 101 MediaThe #1 Crypto for 2024InvestorPlaceDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingHow Biden has already won 2024Porter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Zovio Inc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.